• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Hempacco Co. Inc.

    8/14/24 4:30:30 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email
    NT 10-Q 1 hpco_nt10q.htm FORM NT 10-Q hpco_nt10q.htm

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 12b-25

    SEC FILE NUMBER:

    001-41487

     

    CUSIP NUMBER:

    42371L106

     

    NOTIFICATION OF LATE FILING

     

     

     

    (Check One):

    ☐

    Form 10-K

    ☐

    Form 20-F

    ☐

    Form 11-K

    ☒

    Form 10-Q

    ☐

    Form N-SAR

    ☐

    Form N-CSR

     

    For Period Ended: June 30, 2024

     

     

    ☐

    Transition Report on Form 10-K

     

    ☐

    Transition Report on Form 20-F

     

    ☐

    Transition Report on Form 11-K

     

    ☐

    Transition Report on Form 10-Q

     

    ☐

    Transition Report on Form N-SAR

     

    For the Transition Period Ended:

    Nothing in this form shall be construed to imply that the Commission has

    verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I -- REGISTRANT INFORMATION

     

    Hempacco Co., Inc.

    Full Name of Registrant

     

     

    Former Name if Applicable

    9925 Airway Road

    Address of Principal Executive Office (Street and Number)

     

    San Diego, CA  92154

    City, State and Zip Code

     

     

     

     

    PART II -- RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

     

     

    (a)

    The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

     

     

     

     

    ☐

     

     

    (b)

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

     

     

     

     

     

     

    (c)

    The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III -- NARRATIVE

     

    State below in reasonable detail the reasons why Forms 10-Q, 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.

     

    The registrant has experienced delays in completing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, within the prescribed time period due to delays in completing its audit of its financial statements for the year ending December 31, 2023, assembling the financial information required to be reviewed by the registrant’s independent certifying accountant, and in completing the accounting of transactions affecting the registrant, and as a result, the independent certifying accountant has not completed its review of the registrant’s financial statements for the quarter ended June 30, 2024.

     

    PART IV-- OTHER INFORMATION

     

    (1)

    Name and telephone number of person to contact in regard to this notification

     

     

    Sandro Piancone

     

    619

    779-0715

     

     

    (Name)

     

    (Area Code)

    (Telephone Number)

     

     

    (2)

    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

     

     

     

    Yes

    ☐

     

    No

    ☒

     

    Quarterly Report on Form 10-Q for Three Months Ending March 31, 2024

     

     

    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

     

     

    Yes

    ☐

     

    No

    ☒

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     
    2

     

     

    HEMPACCO CO., INC.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 14, 2024

    By: /s/ Sandro Piancone

     

     

    Sandro Piancone, Chief Executive Officer

     

     

     
    3

     

    Get the next $HPCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    SEC Filings

    See more
    • Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      10/10/24 5:00:29 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      9/9/24 12:45:38 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      8/23/24 4:51:27 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Hempacco Announces Opening of European Office as Part of International Expansion Strategy

      Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

      4/4/23 9:00:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hempacco Receives Notification of Deficiency from Nasdaq

      San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

      5/31/24 4:12:00 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

      NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

      5/6/24 9:30:00 AM ET
      $BNZI
      $HPCO
      $LRHC
      Computer Software: Prepackaged Software
      Technology
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

      NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

      3/28/24 9:15:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Titus Stuart W

      4 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:54 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

      3 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:18 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care